Skip to main content

European Researchers to Use RNAi for Cell Division Study Funded with EUR 8.5M from EU

NEW YORK, July 16 (GenomeWeb News) - A consortium of European researchers has received 8.5 million in funding from the European Union to study cell division, in part by using RNA interference, the European Molecular Biology Laboratory said yesterday.

 

The project, called MitoCheck, includes researchers at EMBL, the Max Planck Institute of Cell Biology and Genetics in Dresden, the Wellcome Trust Sanger Institute, and nine other research institutes in Austria, Germany, Italy, France, and the UK.

 

EMBL scientists plan to study the effects on cell division of suppressing 20,000 genes, one by one, using RNA interference. The MPI in Dressden will provide a library of RNAi molecules. Other partners in the project will use the information to determine the biological regulation of cell division genes.

 

The funding comes from the European Commission's 6th Framework Program.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.